๐Ÿ•ต๏ธ Lisata Therapeutics, Inc. ($LSTA)

SEC insider & ownership activity, last 12 months ยท CIK 320017 ยท every row links its SEC filing

Insiders were quiet over the last 12 months โ€“ no open-market buys or sells. No red-flag 8-Ks in the window.

Insider flow

0 buyers, $0 (0 lots) ยท 0 sellers, $0 (0 lots)

No open-market insider transactions in the last 12 months.

5%+ holders

No current 5%+ beneficial-ownership positions on file.

Planned insider sales (Form 144)

No sale notices filed in the last 12 months.

Material events (8-K)

ItemEvent date
Agreement terminated (1.02)Jul 24, 2026 filing โ†—
Other events (8.01)Jul 24, 2026 filing โ†—
Material agreement (1.01)Jul 16, 2026 filing โ†—
Financial Statements and Exhibits (9.01)Jul 16, 2026 filing โ†—
Material agreement (1.01)Jun 8, 2026 filing โ†—
Financial Statements and Exhibits (9.01)Jun 8, 2026 filing โ†—
Other events (8.01)Jun 1, 2026 filing โ†—
Material agreement (1.01)May 29, 2026 filing โ†—
Financial Statements and Exhibits (9.01)May 29, 2026 filing โ†—
Material agreement (1.01)May 3, 2026 filing โ†—
Financial Statements and Exhibits (9.01)May 3, 2026 filing โ†—
Other events (8.01)Apr 15, 2026 filing โ†—
Other events (8.01)Apr 2, 2026 filing โ†—
Financial Statements and Exhibits (9.01)Apr 2, 2026 filing โ†—
Material agreement (1.01)Mar 6, 2026 filing โ†—
Reg FD disclosure (7.01)Mar 6, 2026 filing โ†—
Financial Statements and Exhibits (9.01)Mar 6, 2026 filing โ†—
Material agreement (1.01)Feb 27, 2026 filing โ†—
Financial Statements and Exhibits (9.01)Feb 27, 2026 filing โ†—
Other events (8.01)Jan 27, 2026 filing โ†—
Material agreement (1.01)Jan 20, 2026 filing โ†—
Other events (8.01)Jan 20, 2026 filing โ†—
Financial Statements and Exhibits (9.01)Jan 20, 2026 filing โ†—
Earnings (2.02)Nov 6, 2025 filing โ†—
Reg FD disclosure (7.01)Nov 6, 2025 filing โ†—
Financial Statements and Exhibits (9.01)Nov 6, 2025 filing โ†—
Reg FD disclosure (7.01)Oct 14, 2025 filing โ†—
Financial Statements and Exhibits (9.01)Oct 14, 2025 filing โ†—
Material agreement (1.01)Oct 8, 2025 filing โ†—
Earnings (2.02)Aug 7, 2025 filing โ†—